MTHFR & High Homocysteine can put patients at risk for Thrombosis, yet no one is testing. Why ?

We speak to Consultant Respiratory Physician Dr Hitasha Rupani, Medicines Consultant Clinical Adviser at NICE Jonathan Underhill and asthma patient Sheba Joseph about NICE’s recently published patient decision aid on asthma inhalers and climate change. The aid supports people with asthma to consider whether they might be able to use inhalers which have a smaller carbon footprint as part of their treatment plan. You can view the patient decision aid by visiting the NICE website: https://bit.ly/3fnLt1K

New patient decision aid on asthma inhalers and climate change

How much does family history affect the chances of being diagnosed with breast cancer and what are the early warning signs? We speak to Professor Andrew Wardley, Breast Cancer Medical Oncologist at The Christie Hospital, Manchester, and Geneva Rhodes, a current patient at The Christie and patient advocate.

Breast Cancer: The significance of family history and looking for early warning signs

Each NICE committee contains at least two patient or patient group representatives. In this episode we find out how NICE's Public Involvement Programme works with these lay members to support their work with NICE and discover what it's like to be a patient representative on a committee. Joining host Matthew Brown are Laura Norburn, senior operations manager for NICE's Public Involvement Programme and Jo Jerrome, chief executive of Thrombosis UK.

How does NICE work with patients and patient groups?

NICE Talks is the podcast from UK's National Institute of Health and Care Excellence (NICE). Our podcast brings the stories behind our NICE's work to improve outcomes for people using the NHS and other public health and social care services through evidence-based guidance.

Subscribe on your favourite podcast platform: https://linktr.ee/nicetalks

How does NICE work with patients and patient groups?

NICE Talks

Recent comments

Michelle Cheatley

Related tracks